Why Research Oversight Bodies Should Interview Research Subjects.

TitleWhy Research Oversight Bodies Should Interview Research Subjects.
Publication TypeJournal Article
Year of Publication2017
AuthorsElliott, C
JournalIRB: Ethics & Human Research
Volume39
Issue2
Pagination8 - 13
Date Published03/2017
PublisherHastings Center
Publication Languageeng
ISBN Number01937758
KeywordsAcademic , ANTIPSYCHOTIC , AUTOMOBILES , Clinical , Corporations , DECISION , Drug , Government , Informed , Institutional , INTERVIEWING , investigational , Minnesota , PANIC , PARANOIA , patient , Patients , product , psychotherapy , research , schizophrenia , United
AbstractThe article offers information on the condition of human subjects in research experiments performed by various universities and governmental organizations. Particular focus is given to the federal regulations related to the use of humans as subjects for experiments and presents the details of a study conducted on Robert Huber to understand the impact of the drug bifeprunox. Other topics addressed include the need for interviewing the subjects of the experiment.
NotesAccession Number: 121908287; Elliott, Carl 1,2; Affiliation: 1: Professor in the Center for Bioethics and the Department of Pediatrics, University of Minnesota 2: Affiliate faculty member in the Department of Philosophy and the School of Journalism and Mass Communications at the University of Minnesota; Source Info: Mar/Apr2017, Vol. 39 Issue 2, p8; Subject Term: SCHIZOPHRENIA; Subject Term: DRUG therapy; Subject Term: CORPORATIONS -- United States; Subject Term: GOVERNMENT policy; Subject Term: ACADEMIC medical centers; Subject Term: ANTIPSYCHOTIC drugs; Subject Term: AUTOMOBILES; Subject Term: CLINICAL trials; Subject Term: INFORMED consent (Medical law); Subject Term: INTERVIEWING; Subject Term: PANIC disorders; Subject Term: PARANOIA; Subject Term: PATIENTS -- Safety measures; Subject Term: PRODUCT recall; Subject Term: PRODUCT safety; Subject Term: PSYCHOTHERAPY patients; Subject Term: DECISION making -- Moral & ethical aspects; Subject Term: INSTITUTIONAL review boards (Medicine); Subject Term: RESEARCH subjects (Persons); Subject Term: PATIENT selection; Subject Term: RESEARCH subjects (Persons) -- Psychology; Subject Term: INVESTIGATIONAL drugs; Subject Term: UNITED States; Subject Term: MINNESOTA; Company/Entity: UNITED States. Food & Drug Administration; NAICS/Industry Codes: 325410 Pharmaceutical and medicine manufacturing; NAICS/Industry Codes: 415110 New and used automobile and light-duty truck merchant wholesalers; NAICS/Industry Codes: 811121 Automotive Body, Paint, and Interior Repair and Maintenance; NAICS/Industry Codes: 423110 Automobile and Other Motor Vehicle Merchant Wholesalers; NAICS/Industry Codes: 441110 New Car Dealers; NAICS/Industry Codes: 336111 Automobile Manufacturing; NAICS/Industry Codes: 811198 All Other Automotive Repair and Maintenance; NAICS/Industry Codes: 336110 Automobile and light-duty motor vehicle manufacturing; NAICS/Industry Codes: 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 6p; Document Type: Article
URLhttp://www.thehastingscenter.org/irb_article/research-oversight-bodies-interview-research-subjects/
Short TitleIRB: Ethics & Human Research

Discipline: 

Subject: 

Publication: